Stock Analyst Insights Feb 2nd: CIGNA, Intuitive Surgical, Vertex

CIGNA Corporation(NYSE:CI): Cigna shares defended on today’s weakness at Leerink.

Intuitive Surgical, Inc.(NASDAQ:ISRG): Collins Stewart confirmed with Intuitive Surgical (NASDAQ:ISRG) management that the Japanese Ministry of Health indicated da Vinci prostatectomy is scheduled to be reimbursed beginning in April. The firm expects Intuitive Surgical, along with its Japanese partner Johnson and Johnson (NYSE:JNJ), to pursue reimbursement for additional procedures. Collins Stewart says it is now more confident in Intuitive Surgical’s long-term growth story and keeps a Buy rating on the stock. Note Lazard Capital said this morning in a note to investors that Japan is moving towards complete da Vinci prostatectomy reimbursement.

ShoreTel, Inc.(NASDAQ:SHOR): ShoreTel shares defended at JP Morgan

Vertex Pharmaceuticals Incorporated(NASDAQ:VRTX): Brean Murray is cautious ahead of Vertex’s report tonight and believes the company could report Incivek sales of $440M below the Street estimate of $470M, which will result in lower 2012 guidance.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at